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and released by astrocytes promoted neurite growth, neuron migration and the arrange-
ment of prospective synapses. In this work we show that alpha-fetoprotein (AFP) is also
present in the brain during embryonic development, its concentrations peaking at E15.5
and at E19.5. However, after E19.5 AFP concentrations plummeted concurrently with a
sharp increase in serum albumin concentrations. At E15.5, AFP is present in caudal regions
of the brain, particularly in brain areas undergoing differentiation during this period, such
as the thalamic reticular nucleus of the thalamus, the hypothalamus, the amygdala and
the hippocampus. Albumin was not detected in the brain at E15.5 but stained brain cells
substantially on day E19.5, showing a very similar distribution to that of AFP under the
same circumstances. The concentrations of free oleic acid in the brain were inversely
correlated with those of AFP, suggesting that the signals elicited by AFP and oleic acid can
be inversely associated. GAP-43, a marker of axonal growth that is highly expressed by the
presence of oleic acid, was not co-localized with AFP except in the marginal zone and areas
delimiting the subplate. AFP prevented the increase in GAP-43 expression caused by the
presence of oleic acid in neurons in primary culture in vitro and in organotypic cultures of
embryonic rat brain ex vivo, suggesting that AFP may modulate the effect of serum albumin
on brain development.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1
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The development of the mamalian brain includes a set of
perfectly coordinated stages that culminate in the formation
of the structures of the mature nervous system. In rodents
and humans, these structures are mainly formed during
prenatal life (Altman and Bayer, 1994; Monuki and Walsh,
2001) and this implies the achievement of a series of perfectly
regulated events that include the development of the neural
tube and its segmentation, neurogenesis, gliogenesis, cell
migration and, eventually, synaptogenesis and the construc-
tion of neural circuits (Wigle and Eisenstat, 2008). These
events take place in a well-controlled microenvironment,
deﬁned by the interchange of substances between three
different interfaces, i.e. the blood, the cerebrospinal ﬂuid
(CSF) and the extracellular space. The composition of these
compartments is regulated by the existence of different brain
barriers: the blood–brain barrier (BBB), the choroid plexus
(blood–CSF barrier), the meningeal barrier and the neuroen-
pendymal barrier (fetal CSF–brain barrier), the latter is rele-
vant exclusively during embryonic development (Saunders
et al., 2008). These barriers limit the passive diffusion of
hydrophilic molecules and hence regulated brain homeosta-
sis (Davson and Segal, 1996; Saunders et al., 2000).
During prenatal brain development, the concentrations of
plasma proteins in CSF are higher than during adult life
(Dziegielewska et al., 2000; Johansson et al., 2008), an observationFig. 1 – Time-course of albumin and alpha-fetoprotein (AFP) leve
AFP concentrations were determined by western blot in brain e
(from E14.5 to P1). For each gestational stage, the brains of at le
analysis of albumin and its quantiﬁcation, (b) Western-blot anal
were normalized against GAPDH and expressed as means7SEM
differences were calculated by One-way ANOVA followed by Tu
signiﬁcant differences (po0.05).classically explained by the apparently immature state of brain
barriers during development. However, it has been demonstrated
that brain barriers are functional early on in development (Ek
et al., 2011) and that the presence of these proteins in brain
compartments is regulated by active transport from the plasma
to the CSF (Dziegielewska et al., 2000; Johansson et al., 2006, 2008;
Saunders et al., 2011). In many mammalian species, the increase
in the concentration of these proteins starts at the beginning of
development, suggesting the occurrence of some relationships
between these changes and the development of the CNS
(Dziegielewska et al., 2000; Medina and Tabernero, 2010). The
two main plasma proteins found in CSF during development are
albumin and alpha-fetoprotein (AFP) (Dziegielewska et al., 1981),
which share some functions, particularly those serving as free-
fatty acid carriers (Calvo et al., 1988). During the embryonic
period, albumin levels were low in CSF but they increased
sharply after birth. AFP followed the opposite pattern because
it shows high concentrations during the embryonic period,
which plunge around birth (Dziegielewska et al., 1981). It has
been suggested that the interchange between albumin and AFP
around the time of birth could be related to important events in
embryonic development (for a review, see Mizejewski (2004)).
In this context, we have previously demonstrated that
serum albumin promotes the synthesis and release of oleic
acid by astrocytes (Tabernero et al., 2001). Albumin is inter-
nalized in astrocytes through endocytosis mediated by mega-
lin and caveolins (Bento-Abreu et al., 2008, 2009. Once in thels in rat brain during embryonic development. Albumin and
xtracts from rat embryos at different developmental stages
ast ﬁve different embryos were analyzed. (a) Western-blot
ysis of alpha-fetoprotein (AFP) and its quantiﬁcation. Results
of the percentages of the levels found at P1. Statistical
key's post-hoc test; different letters indicate statistically
Fig. 2 – Time-course of oleic acid and palmitic acid concentrations in rat brain during embryonic development.
(a) Representative chromatographic proﬁle of fatty acids found in rat brain at E16.5, E20.5 and P1, and their respective
retention times, (b) free fatty acid quantiﬁcation of oleic acid (18:1) and (c) palmitic acid (16:0). Peak areas were quantiﬁed and
values were normalized with added margaric acid (17:0). The results are expressed as nmol/g w/w. (d) Oleic acid/palmitic acid
concentration ratio during the embryonic development. The results are means7SEM from at least ﬁve independent brains.
Statistical differences were calculated by One-way ANOVA followed by Tukey's post-hoc test; different letters indicate
statistically signiﬁcant differences (po0.05).
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esis by inducing stearoyl-CoA desaturase-1 (SCD-1; Tabernero
et al., 2002), a key enzyme in oleic acid synthesis. In addition,
cultured neurons exposed to oleic acid show axonal and
dendritic growth and the expression of growth-associated
protein 43 (GAP-43), a marker of axonal growth (Tabernero
et al., 2001). Moreover, the presence of albumin increases
neuron migration in cultured explants of the lateral periven-
tricular zone, a phenomenon mediated by oleic acid because
silencing SCD-1 by siRNA abolishes the effects of albumin on
cell migration(Polo-Hernandez et al., 2014)
Together, these effects may play a role in perinatal brain
development in vivo because free oleic acid concentrations
increase sharply (6-fold) in the neonatal rat brain during the ﬁrst
day after delivery (Polo-Hernández et al., 2010).This is accompa-
nied by an enhancement of the expression of SCD-1 and GAP-43
(Velasco et al., 2003), suggesting that the neurotrophic effect of
oleic acid observed in cultured neurons and organotypic slices
participates in the postnatal development of the brain.
In the present work we investigated the possible partici-
pation of AFP and albumin in the regulation of brain devel-
opment during the embryonic period. Thus, we investigated
AFP and albumin concentrations in rat brain during this
period and the possible role played by these proteins in the
modulation of the neurotrophic effects of oleic acid. In
addition, the effects of AFP on restraining the neurotrophic
effects of oleic acid in cultured neurons in vitro and in
organotypic cultures ex vivo were studied.2. Results
2.1. Albumin and AFP concentrations in the brain show
different patterns during development
The occurrence of some relationship between the changes in
serum concentrations of albumin and AFP and brain develop-
ment has been suggested previously (Dziegielewska et al., 2000;
Johansson et al., 2006; Medina and Tabernero, 2010). Conse-
quently, in the present work we analyzed the level of these
proteins in rat brain during embryonic and early postnatal
development. In order to accomplish this, brain extracts obtained
from rat fetuses at different developmental stages (from E14.5 to
P1) were assayed by means of Western blotting. Our results
revealed (Fig. 1) that albumin was present in the brain at low
concentrations between E14.5 and E18.5 but its levels increased
sharply between E18.5 and E19.5, thereafter remaining high
afterwards. AFP levels showed a different patterns, remaining
high throughout the embryonic period, with two peaks at E15.5
and at E19.5 (Fig. 1b). The latter peak was concurrent with that
described in CSF (Dziegielewska et al., 1981). During the early
postnatal period the AFP/albumin ratio decreased sharply owing
to the plunge in AFP concentrations, together with the main-
tenance of high concentrations of albumin (Fig. 1).
2.2. Oleic acid concentrations in the brain increases
transiently during embryonic development
We have previously described that free oleic acid concentrations
increase sharply in the brain after birth, which coincided withthe increase in axonogenesis and fasciculation (Polo-Hernández
et al., 2010). However, the concentrations of this fatty acid in the
brain during prenatal development had not yet been assayed.
Accordingly, free fatty acids were extracted from forebrain
homogenates of rat embryos and analyzed by HPLC. On the
basis of the resolution times and internal standard additions,
oleic acid (18:1 n-9) and palmitic acid (16:0) were identiﬁed as the
main free fatty acids occurring in the forebrain during embryonic
life (Fig. 2a and b). Oleic acid levels showed a signiﬁcant peak
during embryonic life, occurring between E15.5 and E18.5
(Fig. 2b). Under these circumstances, the oleic acid/palmitic acid
ratio was about two times higher than that found during the
other parts of embryonic life (Fig. 2c). We also observed a sharply
increase in oleic acid concentrations immediately after birth
(Fig. 2b), in agreement with that previously reported (Polo-
Hernández et al., 2010). It should be stressed that under these
circumstances the oleic/palmitic acid concentrations ratio inver-
sely correlated with AFP concentrations (Fig. 1b), showing a
Pearson's correlation coefﬁcient of r¼0.61 (po0.01).
2.3. AFP and albumin localization in the brain during
embryonic development
The evolution of AFP and albumin concentrations in the brain
during embryonic development and its possible relationship
with those of the neurotrophic factor oleic acid, suggest that
these proteins could play an important role in the develop-
ment of the nervous system. Accordingly, we decided to use
immunohistochemical analysis to determine the localization
of AFP and albumin in brain sections of rat embryos at E15.5
and E19.5, i.e., coinciding with the maximum levels of AFP
found in these circumstances (Fig. 1b). Our results showed
that AFP was markedly located in the developing choroid
plexus (Cpx) and the blood vessels at E15.5 (Fig. 3a). AFP was
mainly present in caudal regions, particularly in those areas
of the brain undergoing differentiation during this period,
such as the thalamic reticular nucleus (TRN) of the thalamus
(Th), the hypothalamus (Ht), the amygdala (Ag) and the
hippocampus (Hpc). AFP was also present in the ﬁbre bundles
of the internal capsule (IC) (Fig. 3a). However, it was almost
absent in the active proliferating neuroepithelium of the
thalamic (TNe) and striatal (Str) area (Fig. 3a). Conversely,
albumin was not detected in the brain at this stage of
development (Fig. 3b), in agreement with the data obtained
with western-blot analysis (Fig. 1a). Nevertheless, the locali-
zation of these proteins changed with the progression of
brain development. Thus, on day E19.5, AFP stained the
ventricular zone (VZ) strongly and, to a lesser extent, also
the subventricular zone (SVZ) (Fig. 3c). It should be mentioned
that during mammalian brain development the neurons
generated from stem cells in the ventricular zone deﬁne their
lineage in the subventricular zone and then migrate radially
to their ﬁnal destination in the cortical plate. The AFP signal
was also higher in the white matter (Wm) areas on both sides
of the subplate (Sp) and also in the marginal zone (MZ).
However, AFP showed a weaker signal in the cortical plate
(CP), in which AFP was distributed in a radial pattern,
emerging from the subplate to the marginal zone. It should
be noted that at this stage of development the pattern of
distribution of AFP persisted along the rostro-caudal axis
Fig. 3 – Inmunohistochemical localization of alpha-fetoprotein (AFP) and albumin in rat brain during embryonic development.
Fluorescence photomicrographs of representative 10 lm coronal sections of E15.5 (a and b) and E19.5 (c and d) brains stained
with anti-AFP and anti-albumin antibodies (green). At E15.5, AFP was detected in many different areas of the embryonic brain
(a) but, at this stage, albumin cannot be detected in any area of the brain (b). However, at E 19.5, AFP and albumin can be
detected in the same regions, although the signal obtained for albumin was weaker (c and d). Cell nuclei were counterstained
with DAPI (blue). Cpx, Choroid-plexus; Hpc, hippocampus; Ncx, Neocortical area; Th, thalamus; TRN, thalamic reticular
nucleus; TNe, thalamic neuroepithelium; Ht, hypothalamus; Ag, amygdala; Str, striatal area; IC, internal capsule; 3rdv, third
ventricle; MZ, marginal zone; Cp, cortical plate; Wm, white matter; Sp, subplate; IZ, intermediate zone; SVZ, subventricular
zone; VZ, ventricular zone; Lv, lateral ventricle. Scale bars represent 250 lm.
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Fig. 4 – Immunohistochemical localization of GAP-43 and alpha-fetoprotein (AFP) in rat brain at E15.5. Confocal
photomicrographs of double immunoﬂuorescence for AFP (green) and for the axonal growth marker GAP-43 (red) on 10 lm
coronal sections of brains at E15.5 ((a–c), from lower to higher magniﬁcation). No co-localization of AFP and GAP-43 proteins
was observed. GAP-43 was mainly detected in external ﬁbre bundles of the thalamic and the hypothalamic areas whereas
AFP was localized in more internal areas such as the amygdala. Cpx, choroid-plexus; Th, thalamus; Ht, hipothalamus; Ag,
amygdala; Str, striatal area; Fb, Fibre bundles.
b r a i n r e s e a r c h 1 6 2 4 ( 2 0 1 5 ) 4 5 – 5 850(data not shown). Unlike what was observed on day E15.5,
albumin stained brain cells substantially on day E19.5
(Fig. 3d), a distribution similar to that of AFP being observed
(Fig. 3c) although the signal was fainter. Nevertheless, albu-
min was found in the ventricular zone, the subplate, the
marginal zone and, subtly, in the cortical plate.
2.4. GAP-43 expression is inversely correlated with AFP
distribution in the brain.
We have previously reported that oleic acid induces neuronal
differentiation in vitro, promoting neurite outgrowth and theexpression of GAP-43, a marker of axonal growth (Tabernero
et al., 2001; see also Medina and Tabernero (2002)). In addi-
tion, during early postnatal life, oleic acid synthesis in the
lateral periventricular zone is followed by an increase in GAP-
43 expression, axonal growth and fasciculation (Polo-
Hernández et al., 2010); this may be due to the effects of
oleic acid on neuronal growth and migration (Polo-Hernandez
et al., 2014). In the present work we observed that the oleic
acid concentration in the brain during embryonic life was
inversely correlated with those of AFP (Figs. 1 and 2). There-
fore, we investigated whether there was a relationship
between GAP-43 expression and AFP concentrations during
Fig. 5 – Immunohistochemical localization of GAP-43 and alpha-fetoprotein (AFP) in rat brain at E19.5. Confocal
photomicrographs of double immunoﬂuorescence for AFP (green) and for the axonal growth marker GAP-43 (red) on 10 lm
coronal sections of brains at E19.5 ((a–c) from lower to higher magniﬁcation). GAP-43 was mainly allocated in more medial
areas of the brain while the signal for AFP increased in more lateral areas. However, AFP and GAP-43 co-localized (yellow) at
the marginal zone and the subplate. In addition, AFP positively-marked ﬁbers can be detected emerging from the subplate to
the marginal zone, passing between the neuronal cell bodies of the cortical plate, positively marked for GAP-43. Cpx, choroid-
plexus; MZ, marginal zone; Cp, cortical plate; Wm, white matter; Sp, subplate; IZ, intermediate zone; SVZ, subventricular
zone; VZ, ventricular zone; Lv, lateral ventricle.
b r a i n r e s e a r c h 1 6 2 4 ( 2 0 1 5 ) 4 5 – 5 8 51embryonic brain development. In order to accomplish this,
we followed the localization of these two proteins by immu-
nohistochemistry and confocal microscopy analysis. Our
results revealed that on E15.5 the expression of AFP and
GAP-43 was inversely allocated (Fig. 4a), GAP-43 mainly being
found in the external ﬁbre bundles (Fb) that delimit the
thalamus (Th) and the hypothalamus (Ht) (Fig. 4b and c),
while AFP was localized in more internal zones. At E19.5 the
separation of these proteins was still apparent, and they weredistributed in an inverse gradient along the medial-lateral
axis (Fig. 5a). Thus, GAP-43 was mainly located in more
medial areas of the brain, while the AFP signal stood out in
more lateral areas. However, these two proteins co-localized
at the marginal zone (MZ) (Fig. 4f) and in some areas
delimiting the subplate (Sp) (Fig. 5b). Despite this, AFP stain-
ing was higher in the white matter region near to the cortical
plate, while the GAP-43 signal was distributed in parallel
bundles along the subplate (Fig. 5b). As mentioned above, in
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b r a i n r e s e a r c h 1 6 2 4 ( 2 0 1 5 ) 4 5 – 5 8 53the cortical plate AFP was distributed in a radial pattern that
crossed between the cell bodies of the cortical parenchyma,
which stained positively for GAP-43.2.5. The presence of AFP prevents the neurotrophic effect
of oleic acid
The results reported in this work suggest that AFP may regulate
brain development during embryonic life by controlling the
neurotrophic effects of oleic acid. To test this hypothesis, we
decided to investigate the possible inhibition of the effects of
oleic acid caused by AFP in neurons in primary culture. Owing
to the possible apoptotic effect of AFP per se on neurons,we ﬁrst
assayed the effect of increasing concentrations of AFP on
neuronal viability (Fig. 6a). Thus, we estimated that the max-
imum concentration of AFP that did not signiﬁcantly alter
neuronal viability in the presence of BSA and oleic acid was
0.0025% (Fig. 6a) and hence this concentration was used for the
analysis of the effect of AFP on neuronal development. In
agreement with previous work carried out by us (Tabernero
et al., 2001; see also Medina and Tabernero (2002)), the presence
of the albumin–oleic acid complex signiﬁcantly increased the
expression GAP-43 in neurons in primary culture (Fig. 6b).
However, under these circumstances the presence of 0.0025%
AFP prevented the effect of the albumin–oleic acid complex on
GAP-43 expression to such an extent that the values observed
in the presence of AFP were lower than those observed with
albumin alone (Fig. 6b). This effect was clearly visualized by
means of immunocytochemistry (Fig. 6c). In this context, oleic
acid promoted neuron migration and aggregation, the neurons
forming clusters connected to each other by axons (Fig. 6c). This
came along with an increase in neurite growth and in GAP-43
staining (Fig. 6d). However, this increase was avoided by the
presence of AFP in the culture medium (Fig. 6d).
This effect was also tested ex vivo in organotypic slices from
E17.5 brains cultured for 48 h in the presence of albumin, the
albumin–oleic acid complex or the albumin–oleic acid complex
plus AFP (Fig. 7). Our results revealed that the presence of
albumin or the albumin–oleic acid complex increased the
expression of GAP-43 (Fig. 7a). The absence of signiﬁcant
differences between the effects of albumin alone and theFig. 6 – Inhibition of the neurotrophic effects of oleic acid by alph
neurons were incubated in the presence of 2% bovine serum alb
BSA (2%)-oleic acid (50 lm) complex supplemented with increasi
No signiﬁcant differences were detected in cell viability when n
those with albumin alone (BSA) or the BSA-oleic acid complex (
thereafter. (b) Western-blot analysis of GAP-43 expression in ne
expressed as percentages of the levels found in the controls (BSA
in the expression of GAP-43, an axonal growth marker. Howeve
culture medium. (c) Immunocytochemical detection of GAP-43 ex
may be observed that AFP prevented the neurotrophic effects of
axonal growth and the clustering of the neurons by their soma.
rat cultured neurons. Total Neurite length per cell of GAP-43-posi
immunohistochemical assays using NIH ImageJ software. Result
three independent experiments. Corrected total cell ﬂuorescence
are expressed as CTFC units and are the mean7SEM of at least
calculated by one-way ANOVA followed by Tukey's post-hoc tes
(po0.05).albumin–oleic acid complex is because astrocytes within the
organotypic slices synthesize oleic acid in situ due to the
presence of albumin (Tabernero et al., 2002; Polo-Hernández
et al., 2010, 2014). Notwithstanding, the presence of AFP
decreased the effect of albumin or the albumin–oleic acid
complex on GAP-43 expression (Fig. 7a), suggesting that AFP
would prevent the effects of oleic acid on axonal growth. In
addition, the presence of albumin or the albumin–oleic acid
complex increased the number of GAP-43-positive axonal
bundles in the lateral periventricular zone, and this effect was
inhibited by the presence of AFP in the culture medium (Fig. 7b).3. Discussion
AFP and albumin are the main proteins detected in CSF during
brain development (Dziegielewska et al., 1981). During the
embryonic period, albumin levels in CSF are low in comparison
with those of AFP, which are higher throughout the intrauterine
period. However, during the perinatal period there is a switch in
the serum AFP/albumin concentration ratio (Dziegielewska et al.,
1981), albumin concentrations increasing towards the high levels
found in adult serum while AFP concentrations decreased
towards mostly negligible levels. These changes have been
associated with brain development and many authors have
stressed the importance of these changes in the conformation
of brain structures (Dziegielewska et al., 2000; Johansson et al.,
2008; Medina and Tabernero, 2010). In this context, the sharp
increase in serum albumin concentrations observed in rat brain
immediately after birth (Velasco et al., 2003) is concurrent with
an increase in free oleic acid levels in the brain (Polo-Hernández
et al., 2010), a phenomenon accompanied by an enhancement of
the expression of MAP-2 and GAP-43, respectively markers of
dendritic and axonal growth (Velasco et al., 2003). In addition, the
presence of albumin promotes the synthesis and release of oleic
acid by astrocytes (Tabernero et al., 2002), which behaves as a
neurotrophic factor for neurons. Thus, the exposure of neurons
to oleic acid promotes dendritic and axonal growth together with
neuron migration, resulting in the aggregation of neurons in
clusters that were connected with each other by axonal pro-
cesses, forming prospective synapses (Tabernero et al., 2001,
Medina and Tabernero, 2002; Polo-Hernandez et al., 2014). Thisa-fetoprotein (AFP) in cultured rat neurons. Primary cultured
umin (BSA), BSA (2%)-oleic acid (50 lm) complex (BSAþO) or
ng concentrations (0.0025—0.02% w/v) of puriﬁed rat AFP (a).
eurons were incubated with 0.0025% AFP as compared to
BSAþO), and hence this APF concentration was used
urons in vitro. The results are means7SEM (n¼3) and are
). The BSA-oleic acid complex induced a signiﬁcant increase
r, this effect was prevented by the presence of AFP in the
pression in rat cultured neurons. Scale bar indicates 50 lm. It
oleic acid, characterized by a higher expression of GAP-43,
(d) Neurite length and GAP-43 ﬂuorescence quantiﬁcation in
tive axons was measured in microphotographs images of the
s are expressed in μm/cell and are the mean7SEM of at least
(CTCF) was quantiﬁed using NIH ImageJ software and results
three independent experiments. Statistical differences were
t; different letters indicate statistical signiﬁcant differences
Fig. 7 – Inhibition of the neurotrophic effects of oleic acid by alpha-fetoprotein (AFP) in cultured organotypic rat brain slices.
Brain slices were prepared from E17.5 brains and cultured for 48 h in the presence of albumin (BSA), the albumin–oleic acid
complex (BSAþO) or the albumin–oleic acid complex supplemented with AFP (BSAþOþAFP). (a) Western-blot analysis of GAP-
43 expression in organotypic rat brain slices. The results are means7SEM (n¼3) and are expressed as the percentages of the
levels found in the controls (BSA). Albumin (BSA) and the albumin–oleic acid complex (BSAþO) signiﬁcantly increased the
expression of GAP-43, but this effect was dramatically reduced by the presence of AFP (BSAþOþAFP).
(b) Immunohistochemical detection of GAP-43 expression in organotypic brain slices. GAP-43-positive ﬁbre bundles can be
observed when organotypic slices were incubated in the presence of albumin alone (BSA) or in the presence of the albumin–
oleic acid complex (BSAþO). It may be observed that AFP prevented the neurotrophic effects of oleic acid, characterized by a
higher expression of GAP-43, axonal growth and the clustering of the neurons by their soma Statistical differences were
calculated by one-way ANOVA followed by Tukey's post-hoc test; different letters indicate signiﬁcant differences (po0.05).
b r a i n r e s e a r c h 1 6 2 4 ( 2 0 1 5 ) 4 5 – 5 854phenomenon is also observed in organotypic cultures ex vivo, in
which albumin promoted axonal growth and fasciculation in the
striatum by a mechanism that depends on oleic acid synthesis
(Polo-Hernández et al., 2010). These results suggest that albumin
may modulate brain development by controlling oleic acid
concentrations locally.
In this work, we provide evidence of the physiological
relevance of AFP in embryonic brain development. Thus, our
results show that AFP is present in the brain during embryonic
development (Figs. 1–5), showing two peaks on E15.5 and E19.5
(Fig. 1b). Under these circumstances, albumin concentrations
remain low, increasing immediately after birth (Fig. 1a). Both
albumin and AFP share ligand-binding properties and can
function as fatty acid carriers (Calvo et al., 1988; Curry et al.,
1999; Bhattacharya et al., 2000; Gillespie and Uversky, 2000). In
agreement with this, a peak in oleic acid levels was detected
between E15.5 and E18.5 (Fig. 2b), coinciding with the develop-
ment of the structures that undergo changes early in the brain
during the embryonic period (Altman and Bayer, 1994). It should
be noted that oleic acid concentrations in brain increased when
the levels of AFP decreased, pointing to an inverse relationship.
This suggests that AFP could regulate the effects of oleic acid
and therefore control brain development during certain speciﬁc
stages. In agreement with this, on E15.5 AFP and the axonal
marker GAP-43 showed an inverse gradient of expression, with
AFP located at the hypothalamus, the thalamic area and the
amygdala, whereas GAP-43 was only detected in more external
areas of the brain (Fig. 4a–c). This inverse gradient was stillpresent at E19.5, but both proteins did co-localize in some
structures, such as the subplate or the cortical plate (Fig. 5a–c).
These results are consistent with the idea that AFP may prevent
GAP-43 expression under these circumstances.
One key point in the formation of the CNS is the establish-
ment of cortico–thalamic connections during embryonic life,
which has been described to be a highly regulated and
perfectly synchronised process (López-Bendito and Molnár,
2003). Early in development, some neurons of the dorsal
thalamus project into the ventral region and then turn
laterally, avoiding the hypothalamus and entering the inter-
nal capsule, where they arrest their progression. Approxi-
mately at the same time, neocortical neurons also extend
their projections, ﬁrst laterally and then ventrally, into the
internal capsule, avoiding the amygdala on their way. Once
they have reached the internal capsule, these projections also
pause in their growth. In the rat, this synchronised pause has
been described to occur approximately between E14.5 and
E15.5 (Jacobs et al., 2007), concurrently with the peak of AFP
levels observed in our experiments (Fig. 1). Moreover, AFP can
be found in the amygdala, thalamus, hypothalamus and the
internal capsule, within it is inversely correlated with GAP-43
(Fig. 4a–c). These areas are strongly involved in the establish-
ment of the connections between the thalamus and the
cortical plate. Hence, our results suggest that AFP could act
as a regulating signal in this process.
As brain development proceeds, thalamocortical connec-
tions resume their growth, extending their axons towards the
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neuronal targets have been developed. Consequently, these
projections accumulated during 2–3 days in the subplate
before they can invade the cortical plate, immediately before
birth (Molnár et al., 1998; Molnár and Cordery, 1999; Price
et al., 2006). At this point, AFP levels increased again, reaching
their maximum at E19.5 and thereafter plunging dramatically
(Fig. 1b). During this pause, the thalamocortical axons are
reorganized and in this process interneurons from the sub-
plate would act as an intermediary link between these
projections and their targets. It should be mentioned that
this pause has been described to be crucial for accurate
formation of future cortical connections (for a review, see
Kanold and Luhmann (2010)). In agreement with this, our
results show (Fig. 5b and c) that GAP-43 positively-stained
axons accumulated underneath the cortical plate, i.e., the
subplate, which also stained strongly for AFP. According to
these data, it is tempting to speculate that AFP might regulate
the establishment of the connections between the thalamus
and the neocortex by inhibiting the development of these
projections. Moreover, the neurotrophic effect of oleic acid
could be involved in the resumption of axonal growth, since
its concentrations increased after the decrease in AFP levels.
To further analyze this issue, we exposed neurons in primary
culture to puriﬁed AFP and observed that the presence of AFP
was indeed able to prevent the neurotrophic effect of oleic
acid (Fig. 6). Moreover, this effect was later conﬁrmed ex vivo
(Fig. 7) because the presence of AFP inhibited GAP-43 expres-
sion together with axonal fasciculation in organotypic cul-
tures of embryonic rat brain challenged with the oleic acid–
albumin complex. Moreover, the effect of AFP was also
observed in organotypic cultures challenged with albumin
alone, suggesting that AFP prevents the effects of oleic acid
synthesized in situ (Fig. 7).
The results reported here suggest that brain development
during the embryonic period is regulated by the AFP/albumin
ratio by modulating the neurotrophic effects of oleic acid. The
balance of both signals may deﬁne neurogenesis at some
speciﬁc stages of embryonic life, while unbalanced ratios may
lead to certain developmental disorders. In this context, the
genetic dosage imbalance caused by the presence of three
copies of some bands of chromosome 21 in Down's syndrome
(DS) result in a defective cortical lamination and hence in an
abnormal brain phenotype (Rachidi and Lopes, 2007). DS has
been associated with a reduction in the levels of both AFP and
albumin in the serum (Nelson, 1961; Voigtlander and Vogel,
1985; Kronquist et al., 1990). This is concurrent with the low
concentrations of monounsaturated fatty acids borne by
brain phospholipids (Shah, 1979), and particularly with a
reduction in the amount of oleic acid borne by phosphati-
dylcholine (Brooksbank and Martínez, 1989). Therefore, the
decrease in the concentrations of both AFP and albumin
observed in DS may be associated with a deregulation in
timing for the formation of brain structures. In the trysomy
16 mouse DS model (Ts16), many cortical plate neurons arrive
at their destination before complete development of the
subplate has been achieved (Cheng et al., 2004). This phe-
nomenon produces alterations in cortical lamination and
hence a reduction in thalamocortical connections. It should
be mentioned that the cortical plate is a region stainedpositively for AFP (Fig. 5), suggesting that the altered subplate
formation observed in DS may be associated with the low AFP
concentrations found in these patients (Nelson, 1961;
Voigtlander and Vogel, 1985; Kronquist et al., 1990). Conver-
sely, a reduction in neurogenesis has been described in a
model of hydrocephaly in vivo, a fact that may be due to the
accumulation of proteins in the CSF during the embryonic
period (Mashayekhi et al., 2002).
Taken together, our results suggest that AFP would play an
important role in brain development during the embryonic
period, participating in a balanced crosstalk with albumin.
This may direct the tempus of the development of speciﬁc
regions of the brain through modulation of the neurotrophic
effects of oleic acid.4. Experimental procedure
4.1. Animals
Albino Wistar rats obtained from the animal house of the
University of Salamanca fed ad libitum on a stock laboratory
diet (49.8% carbohydrates, 23.5% protein, 3.7% fat, 5.5% (w/v)
minerals and added vitamins and amino acids) and main-
tained on a 12 h light–dark cycle were used for the experi-
ments. Rats at embryonic day 14.5 (E14.5) to postnatal day 1
(P1) were used for the western blot and HPLC analyses. E15.5
and E19.5 rats were used for immunohistochemical analyses.
E14.5 rats were used for organotypic slice cultures. E17.5 rats
were used for primary culture of neurons. All animals were
used according to the Spanish (RD 223/88) and European (86/
609/ECC) legislation. The experimental procedure was
approved by Animal Review Board (registered as SAPA001)
of the University of Salamanca (Spain).
4.2. Neuron culture and treatments
Neuron cultures were prepared as previously reported
(Tabernero et al., 2001). Brieﬂy, E17.5 rats were decapitated
and their brains were immediately excised. Cells were dis-
sociated from forebrains and plated onto poly-L-lysine (10 μg/
mL)-coated Petri dishes at a density of 1.5105 cells/cm2. The
culture medium was Dulbecco's Modiﬁed Eagle Medium-F12
(Sigma) supplemented with 5 μg/mL insulin, 100 μg/mL apo-
transferrin, 1 mmol/L pyruvate, 2.5 mmol/L glutamine and a
mixture of antibiotics consisting in 50 U/mL penicillin, 37.5 U/
mL streptomycin and 0,23 mg/mL amphotericin B. Since this
deﬁnite medium does not allow glial growth, more than 95%
of cells in culture were neurons (Tabernero et al., 2001).
Experiments were carried out after 72 h unless otherwise
speciﬁed. Where indicated, the culture medium was supple-
mented with 2% (w/v) albumin (fatty acid-free bovine serum
albumin, Sigma, dialyzed twice against phosphate-buffered
saline; PBS), with 2% albumin plus 50 μM oleic acid (Sigma)
(stock solution 100 mmol/L in 10% fatty acid-free albumin), or
0.0025% (w/v) rat AFP, obtained as described below, plus 2%
albumin and 50 μM oleic acid. For cell viability assays, cells
were supplemented with increasing concentrations (from
0.0025% to 0.02%) of AFP plus 2% albumin and 50 mM oleic
acid immediately after plating.
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The brains of E17.5 rats were carefully dissected and
embedded in 4% (w/v) LMT agarose (Lonza) in PBS and then
sectioned coronally at 250 mm thickness on a vibratome
(Leica). Finally, forebrain slices were transferred to porous
polycarbonate membranes (8 mm diameter Nuclepore Track-
Etched Membranes, Whatman) and cultured for 48 h in
Neurobasal medium supplemented with 20 mL/mL B27, 0.5%
glucose and 50 U/mL penicillin, 37.5 U/mL streptomycin and
0.23 mg/mL amphotericin B. Where stated, the culture med-
ium was supplemented with 2% albumin, with albumin plus
50 mM oleic acid or with 0.0025%AFP plus 2% albumin and
50 μM oleic acid.
4.4. Western blot analyses
Proteins were extracted using a buffer containing 1% Triton X-
100, 50mmol/L Tris–HCl, pH 8, 150mmol/L NaCl, 0.02% sodium
azide, 2 mmol/L EDTA, 2mmol/L EGTA, 1mmol/L phenylmethyl-
sulphonyl ﬂuoride and a protease inhibitor cocktail (Calbiochem).
Lysates were centrifuged at 10,000 g for 10min at 4 1C and the
supernatants were stored at 80 1C. 30 mg of protein extracts
were resolved on 4–12% Bis-Tris pre-cast polyacrylamide gels
(Life technologies) and transferred to a nitrocellulose membrane
with the iBlot system (Life Technologies). The membranes were
blocked for 1 h at room temperature with either 10% (w/v) casein
in 500mmol/L Tris–HCl, pH 7.5, with 2% sodium azide, for
albumin and AFP detection, or with 7% (w/v) low-fat milk in
Tris-buffered saline (10mmol/L Tris, 150mmol/L NaCl, pH 7.6)
for the other proteins. After blocking, the membranes were
incubated for 2 h at room temperature with mouse monoclonal
anti-GAPDH antibody (1:1000, Ambion) and mouse monoclonal
anti-tubulin antibody (1:4000, Sigma), or for 12 h at 4 1C with
mouse monoclonal anti-GAP-43 (1:500, Sigma) antibody, rabbit
polyclonal anti-human AFP antibody (1:2000, DAKO) and rabbit
polyclonal anti-rat albumin antibody (1:2000, ICN Biomedical).
Peroxidase-conjugated anti-mouse IgG or anti-rabbit IgG (1:5000
and 1:10,000 respectively; Santa Cruz Biotechnology, Santa Cruz,
CA, USA) were used and developed with a chemiluminescent
substrate. Membranes were exposed to X-ray ﬁlms (Fujiﬁlm
Corporation, Frankfurt, Germany), which were scanned, and
the intensity of the bands was analyzed using NIH imageJ
software.
4.5. Immunohistochemistry
Immunohistochemical analysis was performed as described
previously (Polo-Hernández et al., 2010) with some modiﬁca-
tions. Brieﬂy, at E15.5 and E19.5 fetuses were aseptically
obtained by post-mortem cesarean collection and perfused
with 4% formaldehyde in PBS. The brains were then post-
ﬁxed in 4% formaldehyde for 12 h at 4 1C. For organotypic
culture, slices were washed in PBS and ﬁxed with 4% formalde-
hyde for 20 min at room temperature. After ﬁxation, the
samples were cryoprotected in 30% (w/v) sucrose for approxi-
mately 24 h at 4 1C and stored frozen at 80 1C embedded in
OCT. Then, tissue samples were sectioned on a cryostat at
10 μm thickness and stored for later processing. For neurons in
primary culture, cells were rinsed with PBS and ﬁxed with 4%paraformaldehyde for 20min at room temperature. The differ-
ent samples were incubated withmousemonoclonal antibodies
against GAP-43 (1:1000), rabbit polyclonal antibodies against
bovine serum albumin (1:500; Calbiochem) or human AFP
(1:500; DAKO) in PBS containing 1% goat serum and 0.1% Triton
X-100 for 12 h at 4 1C. After several rinses in PBS, the sections
were incubated with goat anti-mouse AlexaFluor488 and Alex-
aFluor594 secondary antibody or goat anti-rabbit AlexaFluor488
and AlexaFluor594 secondary antibody (1:1000; Invitrogen) for
1 h at 4 1C. Nuclear DNA was counterstained with 40,6-diami-
dine-20-phenylindole (DAPI 2.5 μg/mL; Life technologies). Sec-
tions were then mounted using the Slowfade Gold Antifade kit
(Life technologies). A Leica inverted ﬂuorescence microscope
connected to a digital video camera (Leica DC100) and a Leica
TCS SP5 confocal microscope were used to obtain ﬂuorescence
images. Controls for immunohistochemistry were carried out
without primary antibodies. Quantitative analysis of neurite
length and corrected total cell ﬂuorescence (CTCF) was per-
formed using the NIH ImageJ software.
4.6. Analysis of oleic acid by HPLC
Forebrain oleic acid was analyzed by HPLC as previously
described (Polo-Hernández et al., 2010), with somemodiﬁcations.
The forebrains were removed immediately after decapitation of
the fetuses and washed in ice-cold PBS for 1 h to remove any
traces of blood. This was assessed by the absence of ﬁbrinogen
by Western blot analysis (Fig. 1b). Then, each forebrain was
homogenized in 2mL of PBS and margaric acid (C17:0, heptade-
canoic acid) was added as an internal control for the quantiﬁca-
tion of free fatty acids. 1.6mL of this solution was used to extract
lipids (Bligh and Dyer, 1959). To accomplish this, 4 mL of a
chloroform: methanol (1: 1) mixture and 2mL PBS 10 were
added and the mixture was centrifuged at 2000 g for 10min. The
lower phase was collected and dried under a nitrogen atmo-
sphere. The extract was then resuspended with 3mL of a n-
hexane:deionized water (2: 1) mixture and centrifuged at 2000 g
for 10min at 25 1C. The upper phase was collected and dried
under a nitrogen atmosphere. This extract was then derivatized
as described previously (Puttmann et al., 1993). Fatty acids were
analyzed as bromophenacyl ester derivatives using HPLCwith an
elution gradient [from 85%: 15% (v/v) acetonitrile: deionized
water to 100% acetonitrile] for 20min, employing a Chromasil
C18 column refrigerated at 0–4 1C. The absorbance of the eluate
wasmonitored at 254 nm. Samples without brain but with added
phosphatidylserine were processed in parallel but no signiﬁcant
phospholipid hydrolysis was detected.
4.7. Puriﬁcation of AFP
Rat AFP was obtained and puriﬁed from the McARH-7777 rat
hepatoma cell line. Brieﬂy, 3 L of hepatoma-conditioned culture
media were collected and concentrated with a Pellicon XL
Biomax-50 device (Millipore) to a volume of approximately
50mL. The concentrated medium was applied to a Bio-Scale
Mini Afﬁ-Gel Blue afﬁnity column (Bio-Rad) in order to remove
albumin. The fraction containing puriﬁed AFP was further
concentrated with an Amicon Ultra-15 centrifugal ﬁlter unit
(Millipore) and subsequently dialysed in Elliot physiological
buffer (Elliot, 1969) for 24 h with a Slide-A-LyzerThermo
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tion was sterilized with a 0.2 mm ﬁlter and stored at 80 1C.4.8. Cell viability assays
To test cell viability, neurons in primary culture were incu-
bated for 72 h with 2% BSA and 50 mM oleic acid and increas-
ing concentrations of AFP. Then, the medium was removed
and cells were incubated with 300 μl of DMEM containing
0.5 mg/ml MTT in the darkness for 75 min. The medium was
then removed and cells were incubated for 10 min in dark-
ness with dimethylsulfoxide (500 μl/well), with mild shaking.
Finally, absorbance was measured at 570 nm using a micro-
plate reader (Multiskan Ascent, Thermo Electron Corporation,
Waltham, MA, USA).4.9. Statistical analyses
When not speciﬁed, results are means7SEM of at least ﬁve
independent experiments. Statistical analyses were carried
out with one-way ANOVA and subsequently followed by the
Tukey's post hoc test in order to classify the data into
homogeneous groups, designated by letters. Values consid-
ered signiﬁcant (po0.05) were designated by different letters.Acknowledgments
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